Correlation Between Humacyte and Icad

Can any of the company-specific risk be diversified away by investing in both Humacyte and Icad at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Humacyte and Icad into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Humacyte and icad inc, you can compare the effects of market volatilities on Humacyte and Icad and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Humacyte with a short position of Icad. Check out your portfolio center. Please also check ongoing floating volatility patterns of Humacyte and Icad.

Diversification Opportunities for Humacyte and Icad

-0.02

Correlation Coefficient

Humacyte  Icad

Good diversification

The 3 months correlation between Humacyte and Icad is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Humacyte and icad inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on icad inc and Humacyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Humacyte are associated (or correlated) with Icad. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of icad inc has no effect on the direction of Humacyte i.e., Humacyte and Icad go up and down completely randomly.

Pair Corralation between Humacyte and Icad

Assuming the 90 days horizon Humacyte is expected to generate 1.92 times more return on investment than Icad. However, Humacyte is 1.92 times more volatile than icad inc. It trades about 0.11 of its potential returns per unit of risk. icad inc is currently generating about 0.02 per unit of risk. If you would invest  48.00  in Humacyte on September 25, 2024 and sell it today you would earn a total of  150.00  from holding Humacyte or generate 312.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.79%
Values	Daily Returns

Humacyte  vs.  icad inc

Humacyte

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Humacyte are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Humacyte may actually be approaching a critical reversion point that can send shares even higher in January 2025.

icad inc

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in icad inc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Icad exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Humacyte and Icad

The main advantage of trading using opposite Humacyte and Icad positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Humacyte position performs unexpectedly, Icad can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icad will offset losses from the drop in Icad's long position.

The idea behind Humacyte and icad inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.